Find Grants for Advance Search
Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Deadline: May 4, 2026
Opportunity Number: PAR-25-106
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 4, 2026
Status: Posted
CFDA Numbers: 93.394, 93.395
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-268
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-267
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-287
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-286
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-235
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.242, 93.879
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Deadline: May 7, 2027
Opportunity Number: PAR-26-001
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.307, 93.273, 93.399, 93.121, 93.279, 93.313
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Deadline: May 7, 2026
Opportunity Number: PAR-25-254
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.399
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Deadline: October 8, 2027
Opportunity Number: PAR-25-248
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: October 8, 2027
Status: Posted
CFDA Numbers: 93.393
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Deadline: November 18, 2027
Opportunity Number: RFA-DA-26-034
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: November 18, 2027
Status: Posted
CFDA Numbers: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
Deadline: October 14, 2027
Opportunity Number: PAR-25-135
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: October 14, 2027
Status: Posted
CFDA Numbers: 93.398
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Deadline: November 19, 2026
Opportunity Number: PAR-25-052
Agency: National Institutes of Health
Open Date: November 20, 2024
Close Date: November 19, 2026
Status: Posted
CFDA Numbers: 93.853
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-112
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.865, 93.173
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-113
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.865, 93.173
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-243
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Deadline: November 16, 2027
Opportunity Number: PAR-25-244
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.393
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-038
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-037
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-228
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.879, 93.172
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-229
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.172, 93.879
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-176
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.351
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-069
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.393
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2027
Opportunity Number: PAR-25-070
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.393
NCMRR Early Career Research Award (R03 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-124
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Deadline: January 7, 2028
Opportunity Number: PA-25-126
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
